Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease
Patient Preference and Adherence2011Vol. 5, pp. 375–375
Citations Over TimeTop 13% of 2011 papers
Abstract
Patients with COPD initiating long-acting bronchodilator therapy were more likely to be adherent to tiotropium than to fluticasone/salmeterol. Adherence to either tiotropium or to fluticasone/salmeterol was associated with lower respiratory-related medical and inpatient costs, and with higher respiratory-related total health care costs.
Related Papers
- → Tiotropium vs. Salmeterol/Fluticasone for COPD(2008)
- Clinical observation of tiotropium combined with salmeterol/fluticasone in treatment of severe chronic obstructive pulmonary disease in stable stage(2012)
- → Observational study on the effects of combining salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease(2013)
- → Evaluation on therapeutic effects of tiotropium combined with salmeterol and fluticasone in treatment of stable COPD patients of group C(2013)